A study to evaluate the effectiveness of Intranasal Salmon Calcitonin Spray on Mandibular and Maxillary Fractures.

To evaluate the efficacy of Intranasal Salmon Calcitonin Spray on bone healing after Open Reduction and Internal Fixation of Maxillary and Mandibular Fractures. - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072733

Enrollment

Registered

2024-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K089- Disorder of teeth and supporting structures, unspecified

Interventions

Intervention1: INTRANASAL SALMON CALCITONIN SPRAY - CALCINASE SPRAY: 3.7ML OF CLEAR SOLUTION WTIH A CONCENTRATION OF 2200IU SALMON CALCITONIN PER ML, AND 0.01% BENZALKONIUM CHLORIDE AS A PRESERVATIVE.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Mandibular and Maxillary Fractures. 2. Patients with moderate systemic diseases, categorized as ASA II.

Exclusion criteria

Exclusion criteria: 1. Patients with adverse outcomes such as postoperative malocclusion, interfragmentary mobility and step deformity. 2. Patients categorized as ASA I, III and IV. 3. Patients diagnosed with pathological lesions of the jaw.

Design outcomes

Primary

Measure	Time frame
1. Postoperative Pain 2. Serum Osteocalcin levels. 3. Radiological Assessment.Timepoint: 1 Month	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Gnanavigneshwaran S

Rajarajeshwari Dental College and Hospital

madhumati_dr@rediffmail.com9841116475

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026